Theralase Technologies Inc (TLT.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2016 | 09-2016 | 06-2016 | 03-2016 | 12-2015 | |
| Sales | 712 | 314 | 482 | 411 | 884 |
| Cost of Goods | 382 | 112 | 150 | 132 | 272 |
| Gross Profit | 330 | 202 | 332 | 280 | 612 |
| Operating Expenses | 1,323 | 1,662 | 1,582 | 1,417 | 1,570 |
| Operating Income | -992 | -1,461 | -1,250 | -1,137 | -958 |
| Interest Expense | 0 | 3 | 0 | 0 | 1 |
| Other Income | -11 | 2 | 6 | -8 | 3 |
| Pre-tax Income | -1,003 | -1,462 | -1,244 | -1,146 | -955 |
| Net Income Continuous | -1,003 | -1,462 | -1,244 | -1,146 | -955 |
| Net Income | $-1,003 | $-1,462 | $-1,244 | $-1,146 | $-955 |
| EPS Basic Total Ops | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 |
| EPS Basic Continuous Ops | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 |
| EPS Diluted Total Ops | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 |
| EPS Diluted Continuous Ops | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 |
| EBITDA(a) | $-985 | $-1,406 | $-1,204 | $-1,108 | $-919 |